|
|
||||||||
Clinical Chemistry, Vol 14, 412-417, Copyright © 1968 by the American Association for Clinical Chemistry
1 Section on Human Biochemical Genetics, National Institute of Arthritis and
Metabolic Diseases, National Institutes of Health, Bethesda, Md. 20014.
An increasing number of recessively inherited human diseases are being explained in terms of a missing or defective enzyme. The resulting aberration of metabolism is reflected, in many cases, in an altered composition of metabolites in the urine and other body fluids. Progress in this field is dependent on making the initial association between a familial disease and an aberration of body chemistry. The development of comprehensive analytic systems for the detection of abnormal quantities or kinds of metabolites in biologic fluids obtained from patients with inherited diseases should greatly facilitate this process. Biochemical characterization, at an enzyme level, then becomes possible and is essential for improved diagnosis and rational approaches to treatment of the disease.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |